Literature DB >> 18045158

Neurogenesis in the adult brain: implications for Alzheimer's disease.

Veronica Galvan1, Dale E Bredesen.   

Abstract

The function of neurogenesis in the adult brain is still unknown. Interventions such as environmental enrichment and exercise impinge on neurogenesis, suggesting that the process is regulated by experience. Conversely, a role for neurogenesis in learning has been proposed through 'cellular plasticity', a process akin to synaptic plasticity but operating at the network level. Although neurogenesis is stimulated by acute injury, and possibly by neurodegenerative processes such as Alzheimer's disease (AD), it does not suffice to restore function. While the role and direction of change in the neurogenic response at different stages of AD is still a matter of debate, it is possible that a deficit in neurogenesis may contribute to AD pathogenesis since at least one of the two regions ostensibly neurogenic in the adult human brain (the subgranular zone of the dentage gyrus and the ventriculo-olfactory neurogenic system) support high-level functions affected in early AD (associative memory and olfaction respectively). The age of onset and the rate of progression of sporadic forms of AD are highly variable. Sporadic AD may have a component of insufficient neurogenic replacement or insufficient neurogenic stimulation that is correlated with traits of personal history; the rate of neurogenesis and the survival of replicating progenitors is strongly modified by behavioral interventions known to impinge on the rate of neurogenesis and the probability of survival of newly born neurons--exercise, enriched experience, and learning. This view is consistent with epidemiological data suggesting that higher education and increased participation in intellectual, social and physical aspects of daily life are associated with slower cognitive decline in healthy elderly ("cognitive reserve") and may reduce the risk of AD. Although neurogenesis can be modulated exogenously by growth factors, stimulation of neurogenesis as a mean to treat neurodegeneration is still for the most part speculative. Moreover, it is possible that different roles of neurogenesis during the course of AD are dictated by the degree of permissibility of the environment in which the process is taking place. A unique opportunity may exist in which the therapeutic stimulation of neurogenesis might contribute to functional 'repair' of the adult diseased brain, before damage to whole neuronal networks has ensued. In spite of the considerable gaps in our knowledge of neurogenesis, and of the considerable limitations that will need to be overcome before we can intervene in the process, that new neurons are added continuously to the adult mammalian brain is a discovery that has already changed the way we think about neurobiology, and may soon change the way we understand and approach neurodegenerative diseases such as AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045158     DOI: 10.2174/187152707783220938

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  18 in total

1.  Tenuigenin promotes proliferation and differentiation of hippocampal neural stem cells.

Authors:  Yujing Chen; Xiaobo Huang; Wenqiang Chen; Ningqun Wang; Lin Li
Journal:  Neurochem Res       Date:  2011-12-18       Impact factor: 3.996

2.  Protective effects of hypothalamic proline-rich peptide and cobra venom Naja Naja Oxiana on dynamics of vestibular compensation following unilateral labyrinthectomy.

Authors:  Armen A Galoyan; Naser Khalaji; Lilja E Hambardzumyan; Larisa P Manukyan; Irina B Meliksetyan; Vergine A Chavushyan; Vaghinak H Sarkisian; John S Sarkissian
Journal:  Neurochem Res       Date:  2010-08-12       Impact factor: 3.996

3.  Clusters of secretagogin-expressing neurons in the aged human olfactory tract lack terminal differentiation.

Authors:  Johannes Attems; Alan Alpar; Lauren Spence; Shane McParland; Mathias Heikenwalder; Mathias Uhlén; Heikki Tanila; Tomas G M Hökfelt; Tibor Harkany
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

4.  Aging and neurogenesis, a lesion from Alzheimer's disease.

Authors:  Philippe Taupin
Journal:  Aging Dis       Date:  2010-04-28       Impact factor: 6.745

Review 5.  Cardiac surgery, the brain, and inflammation.

Authors:  David A Scott; Lisbeth A Evered; Brendan S Silbert
Journal:  J Extra Corpor Technol       Date:  2014-03

6.  Plasticity in Early Alzheimer's Disease: An Opportunity for Intervention.

Authors:  Nikki L Hill; Ann M Kolanowski; David J Gill
Journal:  Top Geriatr Rehabil       Date:  2011-10

Review 7.  Cell migration in the normal and pathological postnatal mammalian brain.

Authors:  Myriam Cayre; Peter Canoll; James E Goldman
Journal:  Prog Neurobiol       Date:  2009-02-11       Impact factor: 11.685

8.  Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease.

Authors:  Robyn A Honea; George P Thomas; Amith Harsha; Heather S Anderson; Joseph E Donnelly; William M Brooks; Jeffrey M Burns
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

9.  A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease.

Authors:  Jason A Bailey; Debomoy K Lahiri
Journal:  J Neurochem       Date:  2009-11-11       Impact factor: 5.372

10.  Doublecortin-expressing cells persist in the associative cerebral cortex and amygdala in aged nonhuman primates.

Authors:  Xue-Mei Zhang; Yan Cai; Yaping Chu; Er-Yun Chen; Jia-Chun Feng; Xue-Gang Luo; Kun Xiong; Robert G Struble; Richard W Clough; Peter R Patrylo; Jeffrey H Kordower; Xiao-Xin Yan
Journal:  Front Neuroanat       Date:  2009-10-13       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.